Prosecution Insights
Last updated: April 19, 2026

Enalare Therapeutics Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18289288 LARGE-CONDUCTANCE POTASSIUM CHANNEL MODULATORS, COMPOSITIONS THEREOF, METHODS OF MANUFACTURING THEREOF, AND METHODS OF USE THEREOF ROBINSON, MIKHAIL O'DONNEL 1627 Non-Final OA Nov 02, 2023
18213451 METHODS OF TREATING NEUROLOGICAL VENTILATORY INSUFFICIENCY MCKOY, QUINCY ANDRE 1626 Non-Final OA Jun 23, 2023
18129538 RESPIRATORY STIMULANT NASAL FORMULATIONS HOWELL, THEODORE R 1628 Non-Final OA Mar 31, 2023

Managing Enalare Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month